TPG Group Holdings (SBS) Advisors’s Vaxcyte PCVX Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$108M	Sell	4,254,390 -304,085	-7%	-$7.37M	1.07%	22
2021 Q2	$103M	Hold	4,558,475	–	–	0.73%	23
2021 Q1	$90M	Sell	4,558,475 -382,738	-8%	-$9.63M	1.05%	22
2020 Q4	$131M	Sell	4,941,213 -215,340	-4%	-$8.01M	1.45%	19
2020 Q3	$255M	Hold	5,156,553	–	–	4.56%	8
2020 Q2	$163M	Buy	+5,156,553	New	+$166M	2.88%	12

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's PCVX Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors reduced its Vaxcyte (PCVX) stake by 6.7% in Q3 2021, selling an estimated $7.37M and leaving 4,254,390 shares worth $108M. The position accounts for 1.07% of the portfolio, ranked #22.

TPG Group Holdings (SBS) Advisors first reported a position in PCVX in Q2 2020 and has held it in 6 quarters since. The position peaked at $255M in Q3 2020. 78 funds tracked by Wall St. Rank hold PCVX as of Q3 2021.

TPG Group Holdings (SBS) Advisors held 4,254,390 shares of Vaxcyte worth $108M as of Q3 2021.
TPG Group Holdings (SBS) Advisors sold 304,085 Vaxcyte shares in Q3 2021, an estimated $7.37M.
Vaxcyte made up 1.07% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #22 holding.
TPG Group Holdings (SBS) Advisors first reported a position in Vaxcyte in Q2 2020 and has held it in 6 quarters since.
TPG Group Holdings (SBS) Advisors's Vaxcyte position peaked at $255M in Q3 2020.
78 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.